Bone metastasis reduces responsiveness to EGFR-TKIs in patients with EGFR-mutated advanced lung adenocarcinoma.

Jiang, K; Lin, G; Zheng, XL; Long, F

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):